Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
| Current Price | ₹165.00 |
|---|---|
| Market Cap | ₹188 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 74.5 |
| Return on Equity | 7.77% |
| 52-Week Range | ₹129.11 – ₹290.78 |
| Beta (1Y) | 0.1 |
1. Textile Segment-14.3% 2. Non-Textile Segment-85.7%
Arvee Laboratories (India) Ltd is trading at ₹165.00, with a market capitalisation of ₹188 Cr.
Arvee Laboratories (India) Ltd operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Arvee Laboratories (India) Ltd has a P/E of 74.5 and a return on equity of 7.77%.